Tumor marker of pancreatic tumor
Ajihara, T.; Shimizu, K.; Shiratori, K.
Nihon Rinsho. Japanese Journal of Clinical Medicine 73(Suppl 3): 45-49
2015
ISSN/ISBN: 0047-1852 PMID: 25856984 Document Number: 679319
Document emailed within 1 workday
Related Documents
Ariyama, J.; Ikenobu, H.; Kurozawa, A.; Kawai, S.; Shirota, K. 1977: Upper abdominal pain and a loss of weight and appetite (radiography of the pancreatic duct and abdominal angiography): (tumor of the pancreatic head--a tumor mainly of the uncinate process and multiple pancreatic cyst) Nihon Rinsho. Japanese Journal of Clinical Medicine 35(Suppl 2): 3106-3107; 3470-3471Venot, J.; Vincent, D.; Clement, M.N.; Beck, C. 1984: Evaluation of a tumor marker of pancreatic cancer. Preliminary results Presse Medicale 13(7): 440-441
Oremek, G.M.; Eigenbrodt, E.; Rädle, J.; Zeuzem, S.; Seiffert, U.B. 1997: Value of the serum levels of the tumor marker TUM2-PK in pancreatic cancer Anticancer Research 17(4b): 3031-3033
Hiramoto, R.N.; Ghanta, V.K.; Soong, S.J.; Hurst, D.C. 1977: An experimental approach to relate a tumor-associated enzyme marker to tumor cell numbers Cancer Research 37(2): 365-368
Oremek, G.M.; Teigelkamp, S.; Kramer, W.; Eigenbrodt, E.; Usadel, K.H. 1999: The pyruvate kinase isoenzyme tumor M2 (Tu M2-PK) as a tumor marker for renal carcinoma Anticancer Research 19(4a): 2599-2601
Hardt, P.D.; Ngoumou, B.K.; Rupp, J.; Schnell-Kretschmer, H.; Kloer, H.U. 2000: Tumor M2-pyruvate kinase: a promising tumor marker in the diagnosis of gastro-intestinal cancer Anticancer Research 20(6d): 4965-4968
Kos, T.; Aksoy, S.; Sendur, M.A.N.; Arik, Z.; Civelek, B.; Kandemir, N.; Ozdemir, N.Y.; Zengin, N.; Altundag, K. 2013: Variations in tumor marker levels in metastatic breast cancer patients according to tumor subtypes Journal of BUON: Official Journal of the Balkan Union of Oncology 18(3): 608-613
Oremek, G.M.; Rutner, F.; Sapoutzis, N.; Sauer-Eppel, H. 2003: Tumor marker pyruvate kinase type tumor M2 in patients suffering from diabetic nephropathy Anticancer Research 23(2a): 1155-1158
McKee, J.S.; Durocher, J.J.; Bose, R.; Gusdal, M.I.; Sharma, G.P.; Pinsky, C.; Gallop, D. 1985: Dynamic studies of positron-emitting putative tumor marker 132Cs in mice show differential tumor and regional uptake Cancer Detection and Prevention 8(1-2): 87-93
Chiewvit, S.; Phasuk, S.; Surapako, S.; Juiklom, W.; Chiewvit, P. 2010: Screening may not be accurate word to represent the cases submitted to PET/CT evaluation for primary tumor in a patient who has abnormal serum tumor marker Journal of the Medical Association of Thailand 93(3): 330-336
Pala, C.; Serventi, F.; Scognamillo, F.; Attene, F.; Pisano, I.Patrizio.; Cugia, L.; Meloni, M.; Trignano, M. 2008: Cystic pancreatic tumor treated by distal spleno-pancreatectomy with occasional diagnosis of neuroendocrine tumor: case report Annali Italiani di Chirurgia 79(6): 451-456
Kobayashi, N.; Fujita, K.; Fujisawa, T.; Takahashi, H.; Yoneda, M.; Abe, Y.; Inamori, M.; Kirikoshi, H.; Kubota, K.; Saito, S.; Nakajima, A. 2008: Which is the best monitoring study (tumor marker, computed tomography or 18F-fluoro-2-deoxy-D-glucose positron emission tomography) to evaluate efficacy of chemotherapy on unresectable pancreatic cancer ? Gan to Kagaku Ryoho. Cancer and ChemoTherapy 35(1): 65-70
Kawa, S.; Oguchi, H.; Homma, T. 1986: Occurrence of pancreatic tumor markers and diagnosis of small pancreatic tumors. 3). POA (pancreatic oncofetal antigen) Nihon Rinsho. Japanese Journal of Clinical Medicine 44(8): 1821-1824
Tanigawa, N.; Mizuno, Y.; Hashimura, T.; Honda, K.; Satomura, K.; Hikasa, Y.; Niwa, O.; Sugahara, T.; Yoshida, O.; Kern, D.H. 1984: Comparison of drug sensitivity among tumor cells within a tumor, between primary tumor and metastases, and between different metastases in the human tumor colony-forming assay Cancer Research 44(6): 2309-2312
Pierrugues, R.; Bories, P.; Marrel, E.; Barneon, G.; Michel, H. 1986: Pancreatic pseudo-tumor caused by bilio-pancreatic tuberculous lymphadenitis. 2 cases Presse Medicale 15(44): 2201-2203
Zámecník, M.; Sedlácek, P.; Gogora, M.; Mukensnábl, P. 1999: A testicular tumor with features of a sex cord tumor with annular tubules and calcified large-cell Sertoli tumor Ceskoslovenska Patologie 35(1): 20-23
Milas, L.; Ito, H.; Hunter, N.; Jones, S.; Peters, L.J. 1986: Retardation of tumor growth in mice caused by radiation-induced injury of tumor bed stroma: dependency on tumor type Cancer Research 46(2): 723-727
Zieglschmid, V.; Hollmann, C.; Mannel, J.; Albert, W.; Jaeschke-Melli, S.; Eckstein, B.; Hillemann, T.; Greten, T.F.; Gross, E.; Böcher, O. 2007: Tumor-associated gene expression in disseminated tumor cells correlates with disease progression and tumor stage in colorectal cancer Anticancer Research 27(4a): 1823-1832
Dvorak, H.F. 1990: Leaky tumor vessels: consequences for tumor stroma generation and for solid tumor therapy Progress in Clinical and Biological Research 354a: 317-330
Hoshino, T.; Jiang, Y.Z.; Dunn, D.; Paul, D.; Qazilbash, M.; Cowan, K.; Wang, J.; Barrett, J.; Liu, J. 1998: Transfection of interleukin-12 cDNAs into tumor cells induces cytotoxic immune responses against native tumor: implications for tumor vaccination Cancer Gene Therapy 5(3): 150-157